• 한국식품영양과학회지
• /
• 제44권2호
• /
• pp.268-274
• /
• 2015

막걸리 제조 부산물인 막걸리박으로부터 추출된 단백질에 다양한 가소제를 첨가하여 막걸리박 단백질(MRP) 필름을 제조하였고, 또한 여러 농도(0, 0.8, 1.0, 1.2%)의 고추냉이 추출물(WE)을 첨가한 MRP 필름을 제조하였다. 사용된 가소제 중 MRP 필름의 물리적 성질을 고려하였을 때 glycerol과 sorbitol을 1:2 비율로 첨가한 경우가 최적 조건이었다. 그리고 WE의 농도가 증가함에 따라 MRP 필름의 인장강도, 신장률, 수분 함량은 감소하였고, MRP 필름의 투습도와 수분용해도는 WE의 농도에 영향을 받지 않았다. 1.0% WE가 함유된 MRP 필름은 Escherichia coli O157:H7과 Listeria monocytogenes에 대해 항균성을 나타내었고, 이를 쇠고기 포장에 적용하였을 때 저장 8일차에서 대조군에 비해 E. coli O157:H7과 L. monocytogenes가 1.1과 0.41 log CFU/g 각각 감소하였다. 또한 저장 중 지방 산화 측정 실험 결과, 1.0% WE가 함유된 MRP 필름으로 포장한 쇠고기는 대조군에 비해 POV 값은 53%, TBARS 값은 56% 감소하였다. 따라서 본 연구 결과 막걸리박에서 추출된 막걸리박 단백질에 1.0% WE를 첨가하여 제조한 가식성 필름은 쇠고기의 저장 중 미생물 억제와 지방 산패 지연에 있어서 효과적인 포장 방법이라고 판단된다.

• Animal cells and systems
• /
• 제1권2호
• /
• pp.363-370
• /
• 1997

RNase MRP is a ribonucleoprotein complex with a site-specific endonuclease activity. Its original substrate for cleavage is the small mitochondrial RNA near the mitochondrial DNA replication origin, thus it was proposed to generate the primer for mtDNA replication. Recently, it has been shown to have another substrate in the nucleus, such as pre-S.8S ribosomal RNA in nucleolus. The gene for the RNA component of RNase MRP (MRP RNA) was found to be encoded by the nucleus genome, suggesting an interesting intracellular trafficking of MRP RNA to both mitochondria and nucleolus after transcription in nucleus. In this study, genomic DNA encoding MRP RNA was microinjected into the nucleus of Xenopus oocytes, to analyze promoter regions involved in the transcription. It showed that the proximal sequence element and TATA box are important for basal level transcription; octamer motif and Sp1 binding sites are for elevated level transcription. Most of Xenopus MRP RNA was exported out to the cytoplasm following transcription in the nucleus. Utilizing various hybrid constructs, export of MRP RNA was found to be regulated by the promoter and the 5' half of the coding region of the gene. Interestingly, the transcription in nucleus seems to be coupled to the export of MRP RNA to cytoplasm. Intracellular transport of injected MRP RNA can be easily visualized by whole-mount in situ hybridization following microinjection; it also shows possible intra-nuclear sites for transcription and export of MRP RNA.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권24호
• /
• pp.10597-10601
• /
• 2015

Up-regulation of multidrug resistance-associated protein 1 (MRP1) is regarded as one of the main causes for multidrug resistance (MDR) of tumor cells, leading to failure of chemotherapy-based treatment for a multitude of cancers. However, whether silencing the overexpressed MRP1 is sufficient to reverse MDR has yet to be validated. This study demonstrated that RNAi-based knockdown of MRP1 reversed the increased efflux ability and MDR efficiently. Two different short haipin RNAs (shRNAs) targeting MRP1 were designed and inserted into pSilence-2.1-neo. The shRNA recombinant plasmids were transfected into cis-dichlorodiamineplatinum-resistant A549 lung (A549/DDP) cells, and then shRNA expressing cell clones were collected and maintained. Real time PCR and immunofluorescence staining for MRP1 revealed a high silent efficiency of these two shRNAs. Functionally, shRNA-expressing cells showed increased rhodamine 123 retention in A549/DDP cells, indicating reduced efflux ability of tumor cells in the absence of MRP1. Consistently, MRP1-silent cells exhibited decreased resistance to 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and DDP, suggesting reversal of MDR in these tumor cells. Specifically, MRP1 knockdown increased the DDP-induced apoptosis of A549/DDP cells by increased trapping of their cell cycling in the G2 stage. Taken together, this study demonstrated that RNAi-based silencing of MRP1 is sufficient to reverse MDR in tumor cells, shedding light on possible novel clinical treatment of cancers.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권5호
• /
• pp.2285-2289
• /
• 2012

Multidrug resistance (MDR) is a main cause of failure in the chemotherapeutic treatment of malignant disorders. One of the well-known genes responsible for drug resistance encodes the multidrug resistance-associated protein (MRP1). The association of MRP1 with clinical drug resistance has not systematically been investigated in Iranian pediatric leukemia patients. We therefore applied real-time RT-PCR technology to study the association between the MRP1 gene and MDR phenotype in Iranian pediatric leukemia patients. We found that overexpression of MRP1 occurred in most Iranian pediatric leukemia patients at relapse. However, no relation between MRP1 mRNA levels and other clinical characteristics, including cytogenetic subgroups and FAB subtypes, was found.

• 품질경영학회지
• /
• 제13권1호
• /
• pp.65-76
• /
• 1985

The purpose of this thesis is to develop a micro-computer application for GT/MRP (group technology/material requirement planning) integrated system for efficient management of production scheduling. GT and MRP system have been found to have several drawbacks in practice. By GT and MRP system, however, it should be able to construct a GT/MRP integrated system that possesses the advantages of both concepts while alleviating their individual limitations.

• Annals of Surgical Treatment and Research
• /
• 제95권5호
• /
• pp.249-257
• /
• 2018

Purpose: Multidrug resistance-associated protein (MRP) 2 is a glutathione conjugate in the canalicular membrane of hepatocytes. Early graft damage after liver transplantation (LT) can result in alteration of MRP2 expression. The purpose of this study was to evaluate the relationship between the pattern of MRP2 alteration and graft outcome. Methods: Forty-one paraffin-embedded liver graft tissues obtained by protocol biopsy within 2 months after LT; these were stained using monoclonal antibodies of MRP2. We selected 15 live donor biopsy samples as a control, that showed homogenous canalicular staining for MRP2. The pattern of canalicular MRP2 staining of graft was classified into 3 types: homogenous (type C0), focal (type C1), and no (type C2,) staining of the canaliculi. Results: In total, 17.1% graft tissues were type C0, 36.6% were type C1, and 46.3% were type C2. The median operation time was longer in patients with type C2 (562.6 minutes) than in patients with type C0 (393.8 minutes) (P = 0.038). The rates of posttransplant complications were higher in patients with type C2 (100%) than in patients with type C0 (42.9%) and C1 (73.3%) (P < 0.001). Conclusion: MRP2 expression pattern was altered in 82.9% after LT. The pattern of MRP2 alteration was associated with longer operation time and higher rates of post-LT complications.

• 산업공학
• /
• 제2권1호
• /
• pp.1-21
• /
• 1989

This paper introduces some practical guidelines which system developer should consider in installing MRP system. And some difficulties which he will encounter and should overcome are illustrated. An MRP software is introduced which was developed by a Korean software company and is being used by several manufacturing companies. Software modules, sturucture of data files and output reports are explained for the software.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권4호
• /
• pp.1639-1642
• /
• 2014

The multidrug resistance phenotype is one of the major problems in development of cancer cell resistance to chemotherapy. Some natural compounds from medicinal plants have demonstrated promising capacity in enhancing anticancer effects in drug resistant cancer cells. We aimed to investigate whether mangiferin might have an ability to re-sensitize MCF-7 breast cancer cells previously treated with short-term doxorubicin in vitro, through the modulation of efflux transporters, P-glycoprotein (P-gp), MRP1 and BCRP. We exposed MCF-7 breast cancer cells pretreated with doxorubicin for 10 days to mangiferin (10, 25 or 50 ${\mu}M$) for 96 hours. Afterwards, we evaluated influence on cell viability and level of mRNA expression of P-gp, MRP1 and BCRP. Doxorubicin given in combination with mangiferin at low concentrations (10 and 25 ${\mu}M$) failed to give significant reduction in cell viability, while at the highest concentrations, the combination significantly reduced cell viability. The mRNA expression analysis of P-gp, MRP1 and BCRP showed that mangiferin had inhibitory effects on P-gp but no effects on MRP1 and BCRP. In conclusion, we suggest that mangiferin at high concentrations can be used as chemosensitizer for doxorubicin therapy. This effect might be attributed by inhibitory effects of mangiferin on P-glycoprotein expression.

• Journal of Yeungnam Medical Science
• /
• 제14권1호
• /
• pp.67-76
• /
• 1997

항암제에 대한 내성은 내인성 또는 획득한 내성 모두가 암의 치료에 장애가 된다. P-당단백질을 encode하고있는 mdr1 유전자의 발현이 항암제에 대해 내성을 가지고 있는 암세포에서 많이 관찰되고 있으며, 최근에는 시험관적으로 항암제에 대한 내성이 유도된 암세포주들에서 mdr1 유전자가 발현되지 않는 암세포들이 보고되고 있다. 다제내성에 관계하는 또 하나의 유전자인 MRP 발현정도를 L1210세포와 내성인 L1210변이주들에서 조사하였으며, c-myc과 c-fos 유전자의 발현변화를 관찰하였다. RT-PCR을 시행하여 L1210, L1210AdR, L1210VcR에서 MRP 유전자발현을 확인하였으며, Northern hybridization한 결과 L1210세포에 비하여 L1210AdR은 유전자 발현이 40% 정도 감소하였으며, L12l0Cis는 90% 정도의 유전자 발현감소가 관찰되었다. c-myc과 c-fos유전자의 Northern hybridization한 결과 L1210에 비하여 L1210AdR은 발현감소가 나타났으나, L1210VcR과 L1210Cis의 경우는 오히려 발현증가가 관찰되었다.

• 산업공학
• /
• 제4권1호
• /
• pp.47-61
• /
• 1991

This paper develops MRP system with two-types of lead time(average lead time and emergent lead time). In this proposed MRP system, Material Requirement Planning is scheduled by using average lead time, but the emergent lead time is used only when start date of planned order is past. Btrieve data management technique and Stack structure are used for recalculating procedure of planned order with the TURBO PASCAL Version 5.5. An example is also considered.